| The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death L Kamalian, AE Chadwick, M Bayliss, NS French, M Monshouwer, ... Toxicology in vitro 29 (4), 732-740, 2015 | 177 | 2015 |
| Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile JA Heslop, C Rowe, J Walsh, R Sison-Young, R Jenkins, L Kamalian, ... Archives of toxicology 91, 439-452, 2017 | 140 | 2017 |
| Increased expression of Id family proteins in small cell lung cancer and its prognostic significance L Kamalian, JR Gosney, SS Forootan, CS Foster, ZZ Bao, C Beesley, ... Clinical Cancer Research 14 (8), 2318-2325, 2008 | 79 | 2008 |
| Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts SS Forootan, ZZ Bao, FS Forootan, L Kamalian, Y Zhang, A Bee, ... International journal of oncology 36 (1), 69-76, 2010 | 49 | 2010 |
| The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity L Kamalian, O Douglas, CE Jolly, J Snoeys, D Simic, M Monshouwer, ... Toxicology in Vitro 53, 136-147, 2018 | 44 | 2018 |
| Identification of the additional mitochondrial liabilities of 2-hydroxyflutamide when compared with its parent compound, flutamide in HepG2 cells AL Ball, L Kamalian, A Alfirevic, JJ Lyon, AE Chadwick Toxicological Sciences 153 (2), 341-351, 2016 | 30 | 2016 |
| Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression Y Zhang, SS Forootan, L Kamalian, ZZ Bao, MI Malki, CS Foster, Y Ke International journal of oncology 38 (4), 1083-1091, 2011 | 22 | 2011 |
| Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression L Kamalian, SS Forootan, ZZ Bao, Y Zhang, JR Gosney, CS Foster, Y Ke International journal of oncology 37 (3), 595-603, 2010 | 19 | 2010 |
| Acute metabolic switch assay using glucose/galactose medium in HepaRG cells to detect mitochondrial toxicity L Kamalian, O Douglas, CE Jolly, J Snoeys, D Simic, M Monshouwer, ... Current protocols in toxicology 80 (1), e76, 2019 | 18 | 2019 |
| The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine CE Jolly, O Douglas, L Kamalian, RE Jenkins, AJ Beckett, SL Penman, ... Toxicology and applied pharmacology 403, 115163, 2020 | 9 | 2020 |
| Mechanism-Based Markers of Drug-Induced Liver Injury to Improve the Physiological Relevance and Predictivity of In Vitro Models C Goldring, A Norris, N Kitteringham, MD Aleo, DJ Antoine, J Heslop, ... Applied in Vitro Toxicology 1 (3), 175-186, 2015 | 9 | 2015 |
| Drug-Induced Liver Injury: Mechanism-Informed Prediction in Drug Development C Goldring, R Weaver, B Kramer, U Klingmueller, A Oppelt, ... Comprehensive Medicinal Chemistry III 4, 217-238, 2017 | 2 | 2017 |
| Evaluating Mitotoxicity as Either a Single or Multi‐Mechanistic Insult in the Context of Hepatotoxicity AL Ball, L Kamalian, CE Jolly, AE Chadwick Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants, 73-92, 2018 | 1 | 2018 |
| The utility of HepG2 cells to identify direct mitochondrial dysfunction L Kamalian, AE Chadwick, M Bayliss, NS French, M Monshouwer, ... | 1 | 2015 |
| GLYCOLYSIS RESPONSE MIGHT OFFER PROTECTION AGAINST HEPATOTOXICITY OF DRUGS WHICH TARGET MITOCHONDRIA L Kamalian, CE Goldring, MZ HASSAN, CE JOLLY, J Snoeys, BK PARK, ... Journal of World Mitochondria Society 1 (2), 2015 | | 2015 |
| Indentification of ID family proteins as promoting dactors in tumourigenesis of small cell lung cancer L Kamalian | | 2010 |
